The definitive benchmark for respiratory dealmaking
Respiratory partnering spans a range of acute and chronic conditions, with deal structures reflecting established treatment paradigms alongside ongoing innovation in biologics, inhaled therapies, and targeted approaches.This report provides a comprehensive and structured analysis of 455 respiratory collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.
Establish a clear view of market standards
The report enables a precise understanding of how respiratory deals are structured in practice, allowing you to:
- Benchmark comparable transactions with confidence
- Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
- Define realistic market parameters
- Clear insight into how deal terms vary by stage, asset type, and partner profile
- Support valuation and structuring decisions with evidence
- Ground internal discussions in real transaction data rather than assumptions
- Understand how leading companies approach dealmaking
- Visibility into partner behaviour and recurring deal structures across a mature yet evolving therapeutic landscape
- Full visibility into deal structure and execution
This includes:
- Rights granted and retained
- Development and commercialization responsibilities
- Financial structures and payment triggers
- Key contractual provisions and protections
Designed for real-world BD and strategy use
The report is widely used to:
- Structure and benchmark live transactions
- Prepare for negotiations with well-defined market context
- Evaluate partnership opportunities and counterparties
- Support internal strategy with robust, defensible data
What’s included?
- 455 respiratory collaboration and licensing deals
- Financial terms, including upfronts, milestones, and royalties where disclosed
- Fully searchable deal directory (by company, therapy, and technology)
- Direct access to SEC-filed agreements and source documents
- Analysis of deal trends, key transactions, and active dealmakers
- A trusted, evidence-based reference for respiratory dealmaking
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in respiratory dealmaking
Chapter 3 - Financial deal terms for respiratory partnering
Chapter 4 - Leading respiratory deals and dealmakers
Chapter 5 - Respiratory contract document directory
Chapter 6 - Respiratory dealmaking by therapeutic target
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M
- 4D Molecular Therapeutics
- 4D Pharma
- AazeinTx
- Abbott Laboratories
- Abbvie
- Abingworth Life Sciences
- Abionic
- ABVC BioPharma
- Acceleron Pharma
- Aclaris Therapeutics
- Acrobat Genomics
- Actelion
- AdAlta
- Adalvo
- Adamis Pharmaceuticals
- adMare BioInnovations
- ADM Tronics
- Advanced Biological Laboratories
- Advanz Pharma
- Advent Therapeutics
- Aerami Therapeutics
- Aerogen
- AeroRx Therapeutics
- Aerpio Pharmaceuticals
- AGC Biologics
- AgeX Therapeutics
- Aidoc
- AirNexis Therapeutics
- AIT Therapeutics
- Akari Therapeutics
- Akonni Biosystems
- Albany Molecular Research
- Alex Therapeutics
- Allakos
- Allegheny Technologies
- Allinaire Therapeutic
- Alpine Immune Sciences
- Altavant Sciences
- Altum Pharmaceuticals
- Aluna
- Alvotech
- American Association for Laboratory Accreditation
- American College of Chest Physicians
- American Lung Association
- Amneal Pharmaceuticals
- AMO Pharma
- Amyndas Pharmaceuticals
- Analytics 4 Life
- AnGes MG
- Anthem
- Anthem Bluecross
- Apple
- Aptar Pharma
- Aptuit
- Arch Biopartners
- Arcturus Therapeutics
- Arena Pharmaceuticals
- Aridis Pharmaceuticals
- Aristea Therapeutics
- Ark Biosciences
- Arrowhead Pharmaceuticals
- ARS Pharmaceuticals
- ArtiQ
- ARUP Laboratories
- Aslan Pharma
- AssisTek
- Asthma UK
- AstraZeneca
- Athersys
- Atrapos Therapeutics
- aTyr Pharma
- Avicenna Technology
- Avrobio
- AzarGen Biotechnologies
- Bausch Health Companies
- Bayer
- Baylor Health Care System
- Beijing Tide Pharmaceutical
- Ben-Gurion University
- BenevolentAI
- Be The Match BioTherapies
- Beth Israel Deaconess Medical Center
- BetterLife Pharma
- Beyond Air
- Bicycle Therapeutics
- Bill and Melinda Gates Foundation
- Bio-Me
- Bio-Techne
- BioAegis Therapeutics
- Bioforum
- BioKey
- BioLink Life Sciences
- Biolojic Design
- BioLum Sciences
- Biomedical Advanced Research and Development Authority
- BioMed X Innovation Center
- Biophytis
- BiosanaPharma
- Biosion
- BioVersys
- Blanver
- Blu Biotech
- Blue Cross Blue Shield Association
- Blue Shield of California
- BNC Korea
- Boehringer Ingelheim
- Bonne Santé Group
- Boomer Esiason Foundation
- Bora Pharmaceuticals
- Boston Scientific
- Boston University School of Medicine
- Brainomix
- Breath Therapeutics
- Bridge Biotherapeutics
- Brigham and Women's Hospital
- BrightInsight
- Bristol-Myers Squibb
- British Lung Foundation
- Broncus Technologies
- Brown University
- C4X Discovery
- California Institute for Biomedical Research
- California Institute for Regenerative Medicine
- Cambridge Healthcare Innovations
- Canadian Blood Services
- Cannex Scientific
- Cantex Pharmaceuticals
- CARB-X
- Cardiff University
- Cardiovascular Systems
- Carnegie Mellon University
- Cedars-Sinai Medical Center
- Celgene
- Cellect Biotechnology
- CELLINK
- Cellix Bio
- Celltrion
- Celularity
- Charak Foundation
- Charite Universitatsmedizin Berlin
- Chiesi Farmaceutici
- Children's Hospital Boston
- China Medical System
- Chronolife
- Cilag AG
- Cincinnati Children’s Hospital Medical Center
- Cipla
- Circassia
- Citius Pharmaceuticals
- Clalit Health Services
- Clario
- CN Bio
- Coalition for Epidemic Preparedness Innovations
- Coeptis Therapeutics
- CohBar
- Collplant
- Combioxin
- Commense
- Commonwealth of Pennsylvania
- CompleWare
- Context Therapeutics
- COPD Foundation
- Corsair Pharma
- Cosmo Pharmaceuticals
- CosmosID
- Covalon Technologies
- COVIRIX Medical
- CRS Bio
- CrystecPharma
- CSL
- CSL Behring
- CS Pharmaceuticals
- Cue Health
- Curadev Pharma
- Curetis
- CureVac
- CVD Equipment
- CytoReason
- Cytovation
- Daewoong Pharmaceutical
- Dalton Pharma Services
- Department of Defense
- Dermira
- Deverra Therapeutics
- DevPro Biopharma
- Diffusion Pharmaceuticals
- Diomics
- Donnelley Financial Solutions
- DSG
- Duke Clinical Research Institute (DCRI)
- Duke University
- Dymax
- Eagle Pharmaceuticals
- Edesa Biotech
- Eisai
- Eli Lilly
- Empatica
- Empirico
- ENA Respiratory
- Endpoint Health
- Enzyvant Science
- Epistemic AI
- Erasmus University Medical Center
- Essential Pharmaceuticals
- Ethris
- European Union
- Everest Medicines
- EvolveImmune Therapeutics
- Evommune
- Evotec
- Experimental Therapeutics Centre of Singapore
- Fannin
- Faron Pharmaceuticals
- FibroGenesis
- Flagship Pioneering
- Florica Therapeutics
- Fluidda
- fluidIQ
- Food and Drug Administration (FDA)
- Foresee Pharmaceuticals
- Forge Therapeutics
- Foundation for Sarcoidosis Research
- Fred Hutchinson Cancer Research Center
- Fujifilm Diosynth Biotechnologies
- FUJIFILM SonoSite
- Fulcrum Therapeutics
- Fusion Genomics
- Galapagos
- Gatehouse Bio
- Geisinger Health System
- GEn1E Lifesciences
- Genentech
- Genomadix
- Genome Institute of Singapore
- GenScript ProBio
- Genten Therapeutics
- German Government
- Getz Healthcare
- Gilead Sciences
- Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals S.A.
- Global Access Diagnostics
- Global Coalition for Adaptive Research
- GlobalLogic
- GoodRx
- Gossamer Bio
- Government of Canada
- Government of Israel
- GPCR Therapeutics
- Graviton Bioscience
- Green Park Collaborative
- GRI Bio
- Grifols
- GSK
- Guangzhou Institute of Respiratory Disease
- Haisco Pharmaceutical
- Hangzhou Chance Pharmaceuticals
- Haplogen
- Harbour Biomed
- Harvard Stem Cell Institute
- Harvard University
- Harvest Capital Strategies
- HCmed Innovations
- Healios K.K.
- Healium Medical
- Health Care Originals
- HealthPrize Technologies
- HealthSnap
- HealthTrust Purchasing Group
- Hebrew University of Jerusalem
- Hemovent
- Henry M. Jackson Foundation
- Highmark Health
- Hikma Pharmaceuticals
- Honeywell
- Hoth Therapeutics
- Humanetics
- Hyfe
- i2c Pharmaceutical Services
- iBio
- IBM
- Icagen
- Iconovo
- IDbyDNA
- IDT Biologika
- Illumina
- Imbio
- Immune Therapeutics
- Imperial College London
- Inari Medical
- Incyte
- Industrial Technology Research Institute
- Inhalation Sciences
- Inhalon Biopharma
- Inhibrx
- Innovare
- Innovate UK
- Innova Vascular
- Innovus Pharmaceuticals
- Inovalon
- Inovio Pharmaceuticals
- Inovytec
- Insmed Inc
- Inspira Technologies
- Instem
- Institut Kanser Negara
- Integrated Computer Solutions
- Intrexon
- Inventiva
- InVixa
- Itamar Medical
- Janssen Pharmaceuticals
- Janssen Research & Development
- Janssen Sciences
- Jemincare
- JHL Biotech
- Jiangsu Hengrui Pharmaceuticals
- Jiangsu QYuns Therapeutics
- Jikei University
- Johannes Gutenberg University
- Johns Hopkins University
- Johnson & Johnson Innovation
- Kaleido Biosciences
- Kamada
- KangWon University Institute of Medical Science
- KARE Biosciences
- Karolinska Institute
- Kashiv BioSciences
- Kelun-Biotech Biopharmaceutical
- Kennedy Institute of Rheumatology
- Keyence
- Kindeva Drug Delivery
- Knopp Biosciences
- Koye Pharmaceuticals
- Kyorin Pharmaceutical
- La Jolla Institute for Allergy & Immunology
- Lassen Therapeutics
- Launch Therapeutics
- Laurel Venture Capital
- Leading BioSciences
- Lee's Pharmaceutical
- Leidos
- LEO Pharma
- LianBio
- LifeArc
- Ligand Pharmaceuticals
- Light Chain Bioscience
- LightDeck Therapeutics
- Lipigon Pharmaceuticals
- Locus Biosciences
- Lonza
- Lotus Pharmaceuticals
- Lumen Biomedical
- Luminex
- LuminUltra
- Lundquist Institute
- Lung Biotechnology
- Lung Therapeutics
- Lung Transplant Foundation
- Lurie Children's Hospital of Chicago
- Lyomark Pharma
- Lyra Therapeutics
- mAbXience
- Mallinckrodt Pharmaceuticals
- MannKind Biopharmaceuticals
- Marinomed Biotechnologie
- Marpai
- Massachusetts General Hospital
- Matrix Biomed
- Max Biopharma
- Mayo Clinic
- Medela
- Mediar Therapeutics
- Medical International Research
- Medical Technology Enterprise Consortium
- Medicines Discovery Catapult
- MediciNova
- Medicom
- MedImmune
- MediPines
- Meissa Vaccines
- Meitheal Pharmaceuticals
- Melinta Therapeutics
- Melior Pharmaceuticals
- Menarini
- Menarini Asia-Pacific
- Merck and Co
- Mesoblast
- Metaba
- Methapharm
- Microbio Shanghai
- Moderna
- Momenta Pharmaceuticals
- Monopar Therapeutics
- Morphic Therapeutic
- Mount Sinai Health System
- MS Pharma
- Mundipharma
- Mylan Pharmaceuticals
- Myovant Sciences
- Nanjing King-friend Biochemical Pharmaceutical
- Nano-X Imaging
- Nanopharm
- NanoString Technologies
- NantKwest
- Nanyang Technological University
- Nashville Biosciences
- National Healthcare Services (NHS)
- National Health Service
- National Heart
- Lung and Blood Institute
- National Institute for Environmental Health Sciences
- National Institute for Health and Care Research Respiratory Translational Research Collaboration
- National Institute of Allergy and Infectious Diseases
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institutes of Health
- National Jewish Health
- National Kidney Foundation
- National Organization for Rare Disorders
- National Research Council Canada
- National Science Foundation
- Nepean Blue Mountains Local Health District’s Nepean Hospital
- Nephron Pharmaceuticals
- NeuCen BioMed
- Neurocare Group
- NeurOp
- NeuroRx
- Nexel
- NitricGen
- Nitto Denko
- North Carolina State University
- NorthStar Medical Radioisotopes
- Northwestern University
- Novartis
- NoveCite
- Novellus Therapeutics
- NRx Pharmaceuticals
- NTC
- Nuance Pharma
- Numedicus
- NuMedii
- NuvoAir
- ObvioHealth
- Olympus Respiratory America
- Omdana Therapeutics
- One BioMed
- Oneness Biotech
- Onymos
- OpGen
- Organicell Regenerative Medicine
- Orgenesis
- Orion
- Oslo University Hospital
- Owkin
- Owlstone Medical
- Palisade Bio
- Pall Corporation
- Pantherics
- Paragonix Technologies
- Paratek Pharmaceuticals
- PARI Pharma
- Partner Therapeutics
- Patara Pharma
- Patient-Centered Outcomes Research Institute
- Peking University
- Penumbra
- Perrigo
- Pharmbio Korea
- PhaseBio Pharmaceuticals
- Philips
- Pieris Pharmaceuticals
- Pluristem Therapeutics
- Polarean Imaging
- Polyphor
- Precisio Biotix Therapeutics
- Precision Image Analysis
- Premier Inc
- Primevera Therapeutics
- Propeller Health
- ProQR Therapeutics
- Protalix BioTherapeutics
- Provista Diagnostics
- Pulmatrix
- Pulmodyne
- Pulmonary Fibrosis Foundation (PFF)
- Pulmonomy
- PulmoSIM Therapeutics
- Pulmotree Medical
- Pulthera
- Punjab Province
- PureTech Health
- QOL Devices
- Quartesian Clinical Research
- Quebec Government
- Quercis Pharma
- R4D Biotech
- Rabin Medical Center (Beilinson Hospital)
- RapidAI
- RAPT Therapeutics
- ReAlta Life Sciences
- Recipharm
- Recludix Pharma
- Recurrent Respiratory Papillomatosis Foundation
- RedHill Biopharma
- Redox
- Redx Pharma
- Relation Therapeutics
- Renovion
- Resilient Biotics
- RespirAI Medical
- Respira Therapeutics
- RespiraWorks
- RespireRx Pharmaceuticals
- resTORbio
- Revon Systems
- RION
- Roche
- Roivant Sciences
- Royal Philips Electronics
- RS BioTherapeutics
- Rubedo Life Sciences
- RxCap
- Samumed
- Sandoz
- Sanofi
- Santhera Pharmaceuticals
- SarcoMed USA
- Sarepta Therapeutics
- Savana
- Savara Pharma
- Scholar Rock
- Science 37
- Scleroderma Research Foundation
- Seelos Therapeutics
- Sema4
- Sensible Medical Innovations
- SenzaGen
- Seqirus
- Seqster
- Serum Institute of India
- Seyltx
- Shandong Luoxin Pharma
- Shanghai Ark Biopharmaceutical
- Shaperon
- Sheba Medical Center
- Shenzhen Institutes of Advanced Technology
- Siemens Healthineers
- Silence Therapeutics
- Simulations Plus
- Siolta Therapeutics
- SiteOne Therapeutics
- Sleepiz
- Sonde Health
- Sonmol
- Sosei Heptares
- SpeeDx
- Spesana
- Spire Health
- SQI Diagnostics
- Stanford University School of Medicine
- Statera Biopharma
- Stemedica Cell Technologies
- Stevanato
- Stimit
- Strados Labs
- Sumitomo Dainippon Pharma
- Sumitovant Biopharma
- Sunnybrook Research Institute
- Sunovion Pharmaceuticals
- SUNY Upstate Medical University
- Surrozen
- Sutter Health
- Suzhou Intragrand Pharma
- Synergie Lyon Cancer
- Synthonics
- Taiba
- Taiho
- Takeda Pharmaceutical
- TARGET PharmaSolutions
- TB Alliance
- TCGFB
- Tektronix Component Solutions
- Teleflex
- Telesair
- TeraRecon
- Tetra Bio-Pharma
- Teva Pharmaceutical Industries
- Texas Lung Injury Institute
- TFF Pharmaceuticals
- TFS International
- The Alfred Hospital
- Therma Bright
- Thermo Fisher Scientific
- Third Pole Therapeutics
- Three Lakes Foundation
- TiGenix
- Tivic Health Systems
- TMM Software
- toSense
- Translate Bio
- Transpire
- Transpire Bio
- Trevena
- TrialSpark
- TSI Healthcare
- United Therapeutics
- University of California
- Davis
- University of California
- San Diego
- University of California San Francisco
- University of Chicago
- University of Colorado
- University of Dundee
- University of Florida
- University of Georgia
- University of Glasgow
- University of Houston
- University of Manchester
- University of Maryland Baltimore
- University of Melbourne
- University of Michigan
- University of Montana
- University of Munster
- University of Oklahoma
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Pittsburgh Medical Center
- University of Sheffield
- University of Surrey
- University of Texas at El Paso
- University of Texas Health Science Center at Tyler
- University of Virginia
- University of Wisconsin
- Urovant Sciences
- US Army
- US Army Medical Research and Material Command
- US Army Medical Research Institute of Chemical Defense
- Utrecht University
- UWM Research Foundation
- Vanderbilt University
- Vapotherm
- Variant Bio
- Vasomune Therapeutics
- Vectura
- Veeva Systems
- VenatoRx
- Veracyte
- Verantos
- Verily
- Verona Pharma
- Vicore Pharma
- Vida Diagnostics
- Virginia Catalyst
- Visby Medical
- Vituity
- Viz.ai
- Vocalis Health
- Vortran Medical
- Watchmaker Genomics
- WaVe Lifesciences
- Weill Cornell Medical College
- Windtree Therapeutics
- Windward Bio
- Wuxi STA
- Wyss Institute
- Xerox
- XL-Protein
- Xvivo Perfusion
- Xylyx Bio
- Yale School of Medicine
- Yale University
- Yissum Research Development
- YPrime
- ZappRx
- Zentiva
- ZEPHYRx
- Zymedi
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
